Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Non-Therapeutic Biomolecules Market Heading Into 2029?

The market for non-therapeutic biomolecules has seen swift growth in the recent past. The market value is projected to increase from $30.76 billion in 2024 to $33.92 billion in 2025, with a compound annual growth rate (CAGR) of 10.3%. The historic growth can be credited to climbing investments in research and development (R&D), expanding use in research and diagnostics, burgeoning adoption and awareness, strategic alliances and partnerships, as well as regulatory backing.

Anticipated to expand rapidly in the subsequent years, the non-therapeutic biomolecules market is set to reach a valuation of $51.03 billion by 2029, with an impressive compound annual growth rate (CAGR) of 10.8%. This projected rise in the forecast period is driven by the emergence of new market opportunities, progresses in data analysis and amalgamation, a mounting focus on precision medicine, increased investments into personalized healthcare, and wider application scope. The forecast period is also expected to see certain key trends such as technological advancements, strategic partnerships, a surge in applications in the agriculture sector, a broadening role in industrial procedures, and an emphasis on customization and personalization.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

Which Factors Are Pushing The Non-Therapeutic Biomolecules Market Forward?

The non-therapeutic biomolecules market is predicted to expand due to the escalating number of research and laboratory tests. Laboratory tests are medical procedures that involve examining bodily samples like blood or urine to identify and track diseases and devise treatment strategies. On the other hand, research involves producing new knowledge or innovatively applying existing knowledge to generate fresh concepts, theories, and comprehensions. Non-therapeutic biomolecules prove useful in lab tests when gauging the existence or concentration of a biomarker molecule denoting disease, thereby increasing the test’s sensitivity and specificity. To illustrate, the UK’s National Health Service (NHS) reported a rise beyond pre-pandemic levels in diagnostic activity in 2024, with diagnostic tests in May 2024 showing a 21% increase as compared to the previous year. Hence, the surging number of research and laboratory tests is fueling the growth of the non-therapeutic biomolecules market.

Which Segment Held The Largest Share In The Non-Therapeutic Biomolecules Market In 2025?

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

How Are Key Trends Driving Expansion In The Non-Therapeutic Biomolecules Industry?

The emergence of product innovations is a notable trend in the non-therapeutic biomolecules market. To maintain their market leadership, predominant companies are investing heavily in research and development for these unique innovations. For example, in January 2022, Caregen, a firm based in Korea dedicated to biomimetic peptide research and development, formed a partnership with BASF SE. This German multinational chemical company subsequently launched the Peptovitae series, which was produced using liposome-encapsulation technology, thus broadening its dermo-cosmetics range to offer diverse and inventive solutions for a variety of skin issues. This encapsulation technique employs fats to transport necessary vitamins or medicines to certain areas of the body in minuscule bubbles while leaving other parts unaffected. The Peptovitae series caters to a more extensive selection of skin problems than what peptides commonly address, such as aging signs, skin dryness, itchiness, and the need for hydration.

Which Organizations Are Driving Progress In The Non-Therapeutic Biomolecules Industry?

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Non-Therapeutic Biomolecules Industry?

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8769&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model